Defective eosinophil chemotaxis to eotaxin in a patient with chronic lower baseline CD4⁺ T-lymphocytes and elevated CD8⁺ T cells

References

• From the Centers for Disease Control. Unexplained CD4+ T-lymphocyte depletion, persons without evident HIV infection. JAMA. 1992;268: 1254–1255.
   Google Scholar
• Smith DK, Neal JJ, Holmberg DD. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States.The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force. N Engl J Med. 1993;328: 373–379.
   PubMed Web of Science ®Google Scholar
• Spira MD, Jones BM, Nicholson JK, et al. Idiopathic CD4+ T-lymphocytyopenia – an analysis of five patients with unexplained opportunistic infections. N Engl J Med. 1993;328:386–392.
   PubMed Web of Science ®Google Scholar
• Duncan RA, von Reyn CF, Alliegro GM, Toossi Z, Sugar AM, Levitz SM. Idiopathic CD4+ T-lymphocytopenia: four patients with opportunistic infections and no evidence of HIV infection. N Engl J Med. 1993;328:393–398.
   PubMed Web of Science ®Google Scholar
• Ho DD, Zhu T, Farthing C, Wang N, Gu G, Schooley RT, Daar ES. Idiopathic CD4+ T-lymphocytopenia-immunodeficiency without evidence of HIV infection. N Eng J Med. 1993;328:429–31.
   PubMed Web of Science ®Google Scholar
• Zonios DI, Falloon J, Bennett JE, et al. Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood. 2008;112: 287–294.
   PubMed Web of Science ®Google Scholar
• Hubert P, Bergeron F, Ferreira V, et al. Defective p56Lck activity in T cells from an adult patient with idiopathic CD4+ lymphocytopenia. Int Immunol. 2000;12:449–457.
   PubMed Web of Science ®Google Scholar
• Torre D, Rossi S, Sampietro C, Broggini M, Quadrelli C. Defective lymphocyte chemotaxis in patients with AIDS. J Infect Dis. 1988;6:1398–1399.
   Google Scholar
• Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med. 1996;2:449–456.
   PubMed Web of Science ®Google Scholar
• Salluto F, Mackay CR, Lanzaveccia A. Selective expression of eotaxin receptor CCR3 by human T helper 2 cells. Science. 1997;26:2005–2007.
   Google Scholar
• Rzepecka J, Donskow-Schmelter K, Doligalska M. Heligmosomoides polygyrus infection down-regulates eotaxin concentration and CCR3 expression on lung eosinophils in murine allergic pulmonary inflammation. Parasite Immunol. 2007;29:405–413.
   PubMed Web of Science ®Google Scholar
• El-Shazly AE, Masuyama K, Ishikawa T. Mechanisms involved in activation of human eosinophil excocytosis by subatance P: An in vitro model of sensory neuroimmunomodulation. Immunol Invest. 1997;26:615–629.
   PubMed Web of Science ®Google Scholar
• El-Shazly A, Berger P, Girodet P, et al. Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma. J Immunol. 2006;176:1860–1868.
   PubMed Web of Science ®Google Scholar
• El-Shazly A, Masuyama K, Eura M, Ishikawa T. Mechanisms involved in human eosinophil chemotaxis induced by the newly cloned C-C chemokine eotaxin. Allergology Inter. 1998;47:9–12.
   Google Scholar
• El-Shazly A, Masuyama K, Samejima Y, Eura M, Ishikawa T. Modulation of normal human eosinophil chemotaxis in vitro by herbimycin A, erbstatin and pervanadate. Int Arch Allergy Immunol. 1998; 117:10–13.
   PubMed Web of Science ®Google Scholar
• Bonecchi R, Bianchi G, Bordignon PP, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1T helper cells (Th1s) and Th2s. J Exp Med. 1998;187:129–134.
   PubMed Web of Science ®Google Scholar
• Gerber BO, Zanni MP, Uguccioni M, et al. Functional expression of the eotaxin receptor CCR3 inT lymphocytes co-localizing with eosinophils. Curr Biol. 1997;7:836–843.
   PubMed Web of Science ®Google Scholar
• Jinquan T, Quan S, Feili G, Larsen CG, Thestrup-Pedersen K. Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4. J Immunol. 1999;162:4285–4292.
   PubMed Web of Science ®Google Scholar
• Franz-Bacon K, Dairaghi DJ, Boehme SA, et al. Human thymocytes express CCR-3 and are activated by eotaxin. Blood. 1999;93: 3233–3240.
   PubMed Web of Science ®Google Scholar
• Zella D, Barabitskaja O, Casareto L, et al. Recombinant IFN-alpha (2b) increases the expression of apoptosis receptor CD95 and chemokine receptors CCR1 and CCR3 in monocytoid cells. J Immunol. 1999;163:3169–3175.
   PubMed Web of Science ®Google Scholar
• Menzies-Gow A, Ying S, Sabroe I, et al. Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J Immunol. 2002;169:2712–2718.
   PubMed Web of Science ®Google Scholar
• Yilmaz-Demirdag Y, Wilson B, Lowery-Nordberg M, Bocchini JA Jr, Bahna SL. Interleukin-2 treatment for persistent cryptococcal meningitis in a child with idiopathic CD4+ T lymphocytopenia. Allergy Asthma Proc. 2008;29:421–424.
   PubMed Web of Science ®Google Scholar
• Wilhelm M, Weissinger F, Kunzmann V, Muller JG, Fahey JL. Idiopathic CD4+ T cell lymphocytopenia evolving to monoclonal immunoglobulins and progressive renal damage responsive to IL-2 therapy. Clin Immunol. 2001;99:298–304.
   PubMed Web of Science ®Google Scholar
• Rundles CC, Murray HW, Smith JP. Treatment of idiopathic CD4 T lymphocytopenia with IL-2. Clin Exp Immunol. 1999;116: 322–325.
   PubMed Web of Science ®Google Scholar
• Warnatz K, Draeger R, Schlesier M, Peter HH. Successful IL-2 therapy for relapsing herpes zoster infection in a patient with idiopathic CD4+ T lymphocytopenia. Immunobiology. 2000;202:204–211.
   PubMed Web of Science ®Google Scholar
• Levy Y, Lacabaratz C, Weiss L, et al. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J Clin Invest. 2009; 119:997–1007.
   PubMed Web of Science ®Google Scholar
• Sportès C, Hakim FT, Memon SA, et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med. 2008;205:1701–1714.
   PubMed Web of Science ®Google Scholar
• Isgrò A, Sirianni MC, Gramiccioni C, Mezzaroma I, Fantauzzi A, Aiuti F. Idiopathic CD4+ lymphocytopenia may be due to decreased bone marrow clonogenic capability. Int Arch Allergy Immunolol. 2005;136:379–384.
   PubMed Web of Science ®Google Scholar
• El-Shazly A, Yamaguchi N, Masuyama K, Suda T, Ishikawa T. Novel association of the src family kinases, hck and c-fgr, with CCR3 receptor stimulation: A possible mechanism for eotaxin-induced human eosinophil chemotaxis. Biochem Biophys Res Commun. 1999;264:163–170.
   PubMed Web of Science ®Google Scholar
• Blumberg RS, Schooley RT. Lymphocytes markers and infectious diseases. Semin Hematol. 1985;22:81–114.
   PubMed Web of Science ®Google Scholar
• Laurence J. T cell subsets in health, infectious disease, and idiopathic CD4+ T lymphocytopenia. Ann Intern Med. 1993;119:55–62.
   PubMed Web of Science ®Google Scholar